Jan. 23—THURSDAY, Jan. 23, 2025 (HealthDay News) — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good ...
Takeda’s Massachusetts presence has undergone ... Could Vertex's non-opioid painkiller capture GLP-1-size market? Sanofi’s Framingham facility hit with FDA warning Sanofi’s Framingham ...
Fractyl was the first Massachusetts company to go through ... priced at $1.94 each as of close of markets on Thursday. Sanofi’s Framingham facility hit with FDA warning ...
THURSDAY, Jan. 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant ... at their Genzyme manufacturing plant in Framingham, ...
Agency cites contamination at Massachusetts plant where company ... ingredients at their Genzyme manufacturing plant in Framingham, Massachusetts. On Jan. 15, 2025, a warning letter was sent to Sanofi ...
(HealthDay News) — The US Food and Drug Administration (FDA) has warned Sanofi about significant ... their Genzyme manufacturing plant in Framingham, Massachusetts. On January 15, a warning ...
an anti-coagulant secreted in the milk of transgenic goats (Capra aegagrus hircus), GTC Biotherapeutics of Framingham, Massachusetts, finally secured US approval for Atryn as well, from CBER.
FRAMINGHAM — The city's long-awaited Raising ... Pike and because the chain plans to extend its hours at all of its Massachusetts locations in the next year. But commissioners raised concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback